Please login to the form below

Not currently logged in
Email:
Password:

Chiesi extends research deal with NiKem

Chiesi Farmaceutici is to extend its research collaboration with NiKem Research, focused on developing treatments within the respiratory therapeutic area

Chiesi Farmaceutici is to extend its research collaboration with NiKem Research, focused on developing treatments within the respiratory therapeutic area.

The two companies have been working together since 2001, with the new deal extending their efforts until 2014.

The collaboration will see NiKem continue its work providing services such as design, lead optimisation and biochemical pharmacology within different therapeutic areas on a fee-for-service basis.

Italy-based Chiesi specialises in products for respiratory pathologies, special care medicine and cardiovascular diseases, with the extended NiKem agreement focused on respiratory illnesses such as asthma and COPD.

Giuseppe Giardina, CEO of NiKem, said: "The scientific and business relationship with Chiesi is rock solid and the current extension follows 10 years of continuous success for both parties in collaborating to identify novel compounds eligible to candidate status for clinical development."

6th September 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics